Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 SEK | +0.37% | -5.63% | -37.60% |
Apr. 13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
Apr. 12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Sales 2024 * | 10M 925K | Sales 2025 * | 116M 10.73M | Capitalization | 135M 12.51M |
---|---|---|---|---|---|
Net income 2024 * | -115M -10.63M | Net income 2025 * | -60M -5.55M | EV / Sales 2024 * | 6.18 x |
Net cash position 2024 * | 73.52M 6.8M | Net cash position 2025 * | 45.95M 4.25M | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
-0.22
x | P/E ratio 2025 * |
-0.56
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.54% |
Latest transcript on Biovica International AB
1 day | +0.37% | ||
1 week | -5.63% | ||
Current month | +1.00% | ||
1 month | -35.47% | ||
3 months | -36.99% | ||
6 months | -38.43% | ||
Current year | -37.60% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Rylander
CEO | Chief Executive Officer | 54 | 09-12-31 |
Anders Morén
DFI | Director of Finance/CFO | 59 | 22-12-31 |
Hanna Ritzen
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 19-03-19 | |
Annika Berg
BRD | Director/Board Member | 61 | 19-12-31 |
Maria Holmlund
BRD | Director/Board Member | 68 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.61 | +0.37% | 88,205 |
24-05-02 | 1.604 | +0.63% | 248,890 |
24-04-30 | 1.594 | -0.25% | 81,390 |
24-04-29 | 1.598 | -6.33% | 296,786 |
24-04-26 | 1.706 | +6.36% | 139,425 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 10:39 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.60% | 12.53M | |
-16.10% | 11.41B | |
-30.20% | 2.3B | |
-14.31% | 2.16B | |
-26.03% | 1.56B | |
+36.95% | 1.19B | |
-2.40% | 760M | |
-19.00% | 506M | |
-38.57% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- BIOVIC B Stock